1. Home
  2. NPKI vs PCRX Comparison

NPKI vs PCRX Comparison

Compare NPKI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

N/A

Current Price

$11.36

Market Cap

1.1B

Sector

Industrials

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$36.33

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NPKI
PCRX
Founded
1932
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
NPKI
PCRX
Price
$11.36
$36.33
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$20.33
★ $33.00
AVG Volume (30 Days)
720.5K
★ 1.6M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 126.16
107.44
EPS
★ 0.26
0.19
Revenue
★ $747,763,000.00
$541,533,000.00
Revenue This Year
$15.38
$3.84
Revenue Next Year
$10.54
$4.73
P/E Ratio
★ $44.15
$191.37
Revenue Growth
★ 58.59
26.04
52 Week Low
$10.73
$18.80
52 Week High
$16.50
$36.46

Technical Indicators

Market Signals
Indicator
NPKI
PCRX
Relative Strength Index (RSI) 31.97 84.48
Support Level $11.20 $21.78
Resistance Level $14.86 N/A
Average True Range (ATR) 0.38 0.69
MACD 0.01 1.14
Stochastic Oscillator 12.45 98.86

Price Performance

Historical Comparison
NPKI
PCRX

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. It generates maximum revenue from United States.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: